Seelos therapeutics announces senior management appointments

New york, sept. 1, 2021 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the promotions of michael golembiewski to chief financial officer and anthony marciano to chief communications officer, each effective september 1, 2021.
SEEL Ratings Summary
SEEL Quant Ranking